Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

Author： Wagenaar H.C.   Pecorelli S.   Mangioni C.   van der Burg M.E.L.   Rotmensz N.   Anastasopoulou A.   Zola P.   Veenhof C.H.N.   Lacave A.J.   Neijt J.P.   van Oosterom A.T.   Einhorn N.   Vermorken J.B.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.13, 2001-09, pp. : 1624-1628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

By van Rijswijk R.E.N.   Vermorken J.B.   Reed N.   Favalli G.   Mendiola C.   Zanaboni F.   Mangili G.   Vergote I.   Guastalla J.P.   ten Bokkel Huinink W.W.   Lacave A.J.   Bonnefoi H.   Tumulo S.   Rietbroek R.   Teodorovic I.   Coens C.   Pecorelli S.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 481-487

Elsevier

Access to resources Recommend Favorite

Should chemotherapy alone be the initial treatment for glottic squamous cell carcinoma? - preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

By Mendenhall W.M.   Tannehill S.P.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1309-1310

Elsevier

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups

By Bosset J.F.   Roelofsen F.   Morgan D.A.L.   Budach V.   Coucke P.   Jager J.J.   Van der Steen-Banasik E.   Triviere N.   Stuben G.   Puyraveau M.   Mercier M.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 45-51

Elsevier

Access to resources Recommend Favorite